CYREN and cancer: The same HERV3 locus has previously been described as a marker of response to immunotherapy in various cancers (41) and lies downstream of the CYREN gene, of which an alternatively spliced transcript encodes the modulator of retrovirus infection (MRI-1) micropeptide (42).